FDA Investigator Sherry G Bous

Sherry G Bous has inspections in 4 countries as of 11 Sep 2023. Sherry G Bous has collaborated with a combinined 3188 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
46
Last Inspection Date:
11 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, India, China, Belgium
Co-Investigator(s):
Adree N Anderson, Alan M Barker, Alberto A Viciedo, Alex M Viehmann, Amir A Abdalla, Ana Paulap Sandee, Ann Marie Montemurro, Ann Marie Schofield, Anthony R Bucks, April K Hill, Arsen Karapetyan, Audrey N Vigil, Azza Talaat, Bei Y He, Blondell W Johnson, Brian R Cronenwett, Bryan S Roddy, Burnell M Henry, Carl A Huffman, III, Carl A Perez, CDR Jeremy L Wally, PhD, Charanjeet Jassal, Chih Jung Hsu, PhD, Christian D Lynch (CDL), Concannon, Cynthia Jim, CSO, David L Miser, Dawn C Olenjack, Dennis Cantellops Paite, Douglas C Kovace, Douglas C Kovacs, Edward E Lockwood (EEL), Eileen A Liu, Elmina E Mboh, Emilio O Escobar, Eric C Nielsen, Eric J Cunningham, Eric M Mueller, PharmD, Eric M Padgett, Erika V Butler, Esther A Ofori, Farhana Khan, Frank J Marciniak, Frank Wackes, Freddy Ortiz Colon, Georgia A Layloff, Gloria J Champagne, Gretchen Lf Trendel, Gwyn G Dickinson, Hongjian Ding, Ingrid Y Johnson, Jacob G Lutz, Jacqueline Mdiaz Albertini, James D Planchon, James I Giefer, Jason K Morgan, Jawaid Hamid, Jay T Wong, Jeffery A Hangartner, Jennifer Cahill, Jill J Tillman, Jogy George, John C Mcmichael, John L Stevens, Johnsont, Jose M Cayuela, Joseph A Piechocki, Joseph R Lambert, Joseph R Strelnik, Juandria Williams, Justin A Boyd, Kara L Roden, Karen C Daugherty, Karen E D'orazio, Karen M Montgomery (KMM), Karthik B Iyer, Katherine Szestypalow, Kathleen B Swat, Kathleen M Bradley, Kellia N Hicks, Kelly D Sheppard, Kendra A Biddick, Kevin A Beavers, Kevin P Foley, Kinh Q Mac, Kshitij A Patkar, Lata C Mathew, PhD, LCDR Audra J Lenhart, LCDR Matthew J Morrison, Li Li, Lisa L Flores, Loan Chin, Luis A Dasta, Margaret A Smithers, Mark R Mcclain, Mary K Concannon, Mary L Schuckmann, Matthew H Hunt, Matthew M Schuckmann, Matthew Ondeck, Matthew R Sleeter, Melba T Rivera, Melba Trivera Clavell, Melissa A Zuppe, Melkamu Getie Kebtie, PhD, Michael A Charles, Michael A Taylor, Michael L Chasey, Michael R Klapal, Michele L Obert, Michele Perry Williams, Mihaly S Ligmond, Mizanne E Lewis, Monica E Murie, Monica M Mcclure, Muralidhara B Gavini, PhD, Nancy G Schmidt, Nancy M Espinal, Nicole E Knowlton, Nikki S Ramirez, Norman K Starks, Omotunde O Osunsanmi, Pamela L Vega, Pankaj H Amin, Patrick C Klotzbuecher, Patrick L Wisor, Paula A Trost, Philip J Boston, Phillip M Pontikos, Prabhu P Raju, Pratik S Upadhyay, DDC, Rajiv R Srivastava, Randa Melhem, PhD, Rick L Friedman, Rita K Kabaso, Robert G Ruff, Robert J Ham, Rohit B Kolhatkar, Rose M Ashley, Samuel K Gibbons, Jr, Sandra A Boyd, Sandra A Hughes, Shafiq S Ahadi, Shanna R Haden, Sharon K Thoma, PharmD, Sheri L Stephenson, Shirley J Berryman, Shirshendu K Deb, PhD, Sidney B Priesmeyer, Simone E Pitts, State Agency, Steven D Kehoe, Susanna E Ford, Analyst, Tara L Breckenridge, Tara L Greene, Thomas J Arista, Thuy T Nguyen, LCDR, Tiara Nbrown Crosen, Torrey M Ward, Unnee Ranjan, Verlinda A Narcisse, Veronica L Call, Walden H Lee, Warren J Lopicka, Wayne D Mcgrath, Wei Wang, PhD, William C Corley, William F Lagud, Jr, William Hallett, PhD, Xikui Chen (nmi), PhD, Xiuju Lu, Yaodong Huang, Yasamin Ameri, Yonggang Wang, PhD, Yvesna C Blaise, Zachary A Bogorad, Zakaria I Ganiyu, Zedong Dong, Zhong Li, PhD

Sherry G Bous's Documents

Publish Date Document Type Title
June, 2011 FDA 483 Genzyme Corporation - Form 483, 2011-06-21
October, 2010 FDA 483 Response Weinstock, Dr Leonard - Form 483R, 2010-10-18
March, 2016 EIR LUPIN LIMITED - EIR, 2016-03-11
July, 2009 FDA 483 Meridian Medical Technologies, LLC - Form 483, 2009-07-31
March, 2011 FDA 483 Marcus Research Laboratory, Inc. - Form 483, 2011-03-14
October, 2010 FDA 483 Weinstock, Dr Leonard - Form 483, 2010-10-08
June, 2013 FDA 483 Baxalta Belgium Manufacturing SA - Form 483, 2013-06-18
March, 2015 EIR Hunan Dongting Pharmaceutical Co., Ltd. - EIR, 2015-03-06
February, 2010 FDA 483 PTI Union LLC - Form 483, 2010-02-18
March, 2010 FDA 483 Reliable Biopharmaceutical LLC - Form 483, 2010-03-24
September, 2009 FDA 483 Sigma-Aldrich Mfg LLC - Form 483, 2009-09-02
May, 2011 FDA 483 Cardinal Health 414, LLC - Form 483, 2011-05-10
March, 2016 FDA 483 Response LUPIN LIMITED - Form 483R, 2016-03-31
November, 2010 FDA 483 CoreLink LLC - Form 483, 2010-11-12
January, 2017 EIR Zydus Lifesciences Limited - EIR, 2017-01-24
March, 2011 EIR Marcus Research Laboratory, Inc. - EIR, 2011-03-14
October, 2013 FDA 483 Meridian Medical Technologies Inc., A Pfizer Company - Form 483, 2013-10-09
June, 2011 FDA 483 Huvepharma, Inc. - Form 483, 2011-06-16
June, 2009 FDA 483 Consolidated Chemical, Inc. DBA CARE-TECH Laboratories, Inc. - Form 483, 2009-06-12
June, 2013 EIR Baxalta Belgium Manufacturing SA - EIR, 2013-06-18
November, 2013 EIR Hubei Biocause Heilen Pharmaceutical Co., Ltd - EIR, 2013-11-22
October, 2010 EIR Weinstock, Dr Leonard - EIR, 2010-10-08
March, 2016 FDA 483 LUPIN LIMITED - Form 483, 2016-03-11

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more